Mevalonic acid

Mevalonic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Mevalonic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Mevalonic acid

MeSH term MeSH ID Detail
Celiac Disease D002446 16 associated lipids
Biliary Fistula D001658 13 associated lipids
Xanthomatosis D014973 17 associated lipids
Smith-Lemli-Opitz Syndrome D019082 7 associated lipids
Peutz-Jeghers Syndrome D010580 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Mevalonic acid

Download all related citations
Per page 10 20 50 100 | Total 2899
Authors Title Published Journal PubMed Link
Mokashi V et al. Supernatant protein factor stimulates HMG-CoA reductase in cell culture and in vitro. 2005 Arch. Biochem. Biophys. pmid:15581604
Yazawa H et al. Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells. 2005 J. Periodontol. pmid:15974856
Han KH et al. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. 2005 Circulation pmid:15781755
Baker SK and Tarnopolsky MA Statin-associated neuromyotoxicity. 2005 Drugs Today pmid:16034491
Argmann CA et al. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. 2005 J. Biol. Chem. pmid:15817453
Murthy S et al. Regulation of fatty acid synthesis by farnesyl pyrophosphate. 2005 J. Biol. Chem. pmid:16221687
Ota K et al. Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene. 2005 Metab. Clin. Exp. pmid:15690306
Bevilacqua M et al. Bisphosphonates and atherosclerosis: why? 2005 Lupus pmid:16218486
Seker T et al. Analysis of acyl CoA ester intermediates of the mevalonate pathway in Saccharomyces cerevisiae. 2005 Appl. Microbiol. Biotechnol. pmid:15448940
Kim J et al. 4,8-Dimethyldecanal, the aggregation pheromone of Tribolium castaneum, is biosynthesized through the fatty acid pathway. 2005 J. Chem. Ecol. pmid:16222778
Baker SK Molecular clues into the pathogenesis of statin-mediated muscle toxicity. 2005 Muscle Nerve pmid:15712281
Donovan JM et al. Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia. 2005 Dig. Dis. Sci. pmid:16047465
Hargreaves IP et al. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications. 2005 Drug Saf pmid:16048353
Duncan RE et al. Dietary factors and the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for breast cancer and development. 2005 Mol Nutr Food Res pmid:15617098
Duncan RE et al. Statins and cancer development. 2005 Cancer Epidemiol. Biomarkers Prev. pmid:16103434
Girlanda S et al. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes. 2005 Cancer Res. pmid:16103105
Tucker DE et al. Group IVC cytosolic phospholipase A2gamma is farnesylated and palmitoylated in mammalian cells. 2005 J. Lipid Res. pmid:16061942
Bocci G et al. Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells. 2005 Br. J. Cancer pmid:16052215
Luckman SP et al. JBMR anniversary classic. Nitrogen-containing biophosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. Originally published in Volume 7, number 4, pp 581-9 (1998). 2005 J. Bone Miner. Res. pmid:16050006
Madonna R et al. Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts. 2005 J. Biol. Chem. pmid:15705589
Saiki A et al. Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes. 2005 J. Atheroscler. Thromb. pmid:16020917
Wei H et al. Statin-inhibited endothelial permeability could be associated with its effect on PECAM-1 in endothelial cells. 2005 FEBS Lett. pmid:15710425
Paradisi M et al. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress. 2005 BMC Cell Biol. pmid:15982412
Viereck V et al. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts. 2005 J. Cell. Biochem. pmid:16152630
Sacher J et al. Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. 2005 J. Pharmacol. Exp. Ther. pmid:15914674
Wang C et al. Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication. 2005 Mol. Cell pmid:15893726
Mahmud T et al. A biosynthetic pathway to isovaleryl-CoA in myxobacteria: the involvement of the mevalonate pathway. 2005 Chembiochem pmid:15619721
Okada K and Hase T Cyanobacterial non-mevalonate pathway: (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase interacts with ferredoxin in Thermosynechococcus elongatus BP-1. 2005 J. Biol. Chem. pmid:15792953
Mantha AJ et al. Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor. 2005 Clin. Cancer Res. pmid:15788691
McCarey DW et al. Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? 2005 Arthritis Res. Ther. pmid:15743490
Pedrini S et al. Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. 2005 PLoS Med. pmid:15647781
Zeng L et al. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation. 2005 FASEB J. pmid:16160062
Luebker DJ et al. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. 2005 Toxicology pmid:16129535
Duncan RE et al. Delivery of mevalonate to murine extrahepatic tissues via mini-osmotic pumps. 2004 Sep-Oct J Pharmacol Toxicol Methods pmid:15385088
Ruiz-Velasco N et al. Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands Putative contribution of Rho GTPases in statin-induced CD36 expression. 2004 Biochem. Pharmacol. pmid:14698043
Schulz JG et al. HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis. 2004 J. Neurochem. pmid:15030386
Danesh FR and Kanwar YS Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy. 2004 FASEB J. pmid:15117885
Kizu A et al. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators. 2004 J. Cell. Biochem. pmid:15389884
Suzuki M et al. Loss of function of 3-hydroxy-3-methylglutaryl coenzyme A reductase 1 (HMG1) in Arabidopsis leads to dwarfing, early senescence and male sterility, and reduced sterol levels. 2004 Plant J. pmid:14871314
Dubuc G et al. Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:15178557
Rasouli M et al. Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes. 2004 Biochim. Biophys. Acta pmid:15158760
Gerber R et al. Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC-MS. 2004 Anal. Biochem. pmid:15136164
Bi X et al. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia. 2004 J. Biol. Chem. pmid:15364922
del Real G et al. Statins inhibit HIV-1 infection by down-regulating Rho activity. 2004 J. Exp. Med. pmid:15314078
Peña-Diaz J et al. Mitochondrial localization of the mevalonate pathway enzyme 3-Hydroxy-3-methyl-glutaryl-CoA reductase in the Trypanosomatidae. 2004 Mol. Biol. Cell pmid:14699057
Rodríguez JM et al. Fungal metabolic model for 3-methylcrotonyl-CoA carboxylase deficiency. 2004 J. Biol. Chem. pmid:14612443
Bate C et al. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. 2004 J. Biol. Chem. pmid:14754889
Sauane M et al. Leukaemia inhibitory factor or oncostatin M induction of Swiss 3T3 cells does not require mevalonic acid synthesis nor protein isoprenylation to initiate DNA replication. 2004 Biochem. Biophys. Res. Commun. pmid:14706631
Panda T and Devi VA Regulation and degradation of HMGCo-A reductase. 2004 Appl. Microbiol. Biotechnol. pmid:15558272
Fuse M et al. Regulation of geranylgeranyl pyrophosphate synthase in the proliferation of rat FRTL-5 cells: involvement of both cAMP-PKA and PI3-AKT pathways. 2004 Biochem. Biophys. Res. Commun. pmid:14985133
Tabata K and Hashimoto S Production of mevalonate by a metabolically-engineered Escherichia coli. 2004 Biotechnol. Lett. pmid:15604784
Zanotti I et al. Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells. 2004 Biochem. Biophys. Res. Commun. pmid:15358158
Sutherlin A and Rodwell VW Multienzyme mevalonate pathway bioreactor. 2004 Biotechnol. Bioeng. pmid:15286992
Schwartz CC et al. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. 2004 J. Lipid Res. pmid:15145983
Dickschat JS et al. Biosynthesis of volatiles by the myxobacterium Myxococcus xanthus. 2004 Chembiochem pmid:15174160
Ikeuchi H et al. Fluvastatin reduces renal fibroblast proliferation and production of type III collagen: therapeutic implications for tubulointerstitial fibrosis. 2004 Nephron Exp. Nephrol. pmid:15331935
Saijonmaa O et al. Atorvastatin completely inhibits VEGF-induced ACE upregulation in human endothelial cells. 2004 Am. J. Physiol. Heart Circ. Physiol. pmid:14704227
Umlauf D et al. Biosynthesis of the irregular monoterpene artemisia ketone, the sesquiterpene germacrene D and other isoprenoids in Tanacetum vulgare L. (Asteraceae). 2004 Phytochemistry pmid:15381410
Tringali G et al. Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase. 2004 Neurosci. Lett. pmid:14698450
Bellosta S et al. Statins effect on smooth muscle cell proliferation. 2004 Semin Vasc Med pmid:15861311
Hedl M et al. Class II 3-hydroxy-3-methylglutaryl coenzyme A reductases. 2004 J. Bacteriol. pmid:15028676
Barkley SJ et al. Identification of an Archaeal type II isopentenyl diphosphate isomerase in methanothermobacter thermautotrophicus. 2004 J. Bacteriol. pmid:14996812
Patel NV and Forman BM Linking lipids, Alzheimer's and LXRs? 2004 Nucl Recept Signal pmid:16604185
Raschke M et al. A high-performance liquid chromatography method for the analysis of intermediates of the deoxyxylulose phosphate pathway. 2004 Anal. Biochem. pmid:15556562
Tokoro T et al. The novel HMG-CoA reductase inhibitor, Pitavastatin, induces a protective action in vascular endothelial cells through the production of nitric oxide (NO). 2004 Yakugaku Zasshi pmid:15049129
Kawasaki T et al. Presence of copalyl diphosphate synthase gene in an actinomycete possessing the mevalonate pathway. 2004 J. Antibiot. pmid:15712669
Inomata M et al. Biosynthesis of abscisic acid by the direct pathway via ionylideneethane in a fungus, Cercospora cruenta. 2004 Biosci. Biotechnol. Biochem. pmid:15618629
Friesen JA and Rodwell VW The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. 2004 Genome Biol. pmid:15535874
Sauter GH et al. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects. 2004 Digestion pmid:15375335
Fan P et al. Pitavastatin, a potent hydroxymethylglutaryl coenzyme a reductase inhibitor, increases cholesterol 7 alpha-hydroxylase gene expression in HepG2 cells. 2004 Circ. J. pmid:15502389
Ferrara DE et al. Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. 2004 J. Thromb. Haemost. pmid:15333031
Vaughan CJ and Gotto AM Update on statins: 2003. 2004 Circulation pmid:15313959
Werner M et al. Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. 2004 Br. J. Pharmacol. pmid:15289292
Siddals KW et al. Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathways. 2004 J. Biol. Chem. pmid:15247258
Ando H et al. Effects of pravastatin on the expression of ATP-binding cassette transporter A1. 2004 J. Pharmacol. Exp. Ther. pmid:15210833
Stojanov S et al. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. 2004 Arthritis Rheum. pmid:15188372
Duncan RE et al. Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity. 2004 J. Biol. Chem. pmid:15155733
Hedl M and Rodwell VW Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii. 2004 Protein Sci. pmid:15152097
Kuzuyama T et al. Heterologous mevalonate production in Streptomyces lividans TK23. 2004 Biosci. Biotechnol. Biochem. pmid:15118326
Andreassi JL et al. Streptococcus pneumoniae isoprenoid biosynthesis is downregulated by diphosphomevalonate: an antimicrobial target. 2004 Biochemistry pmid:15610040
Andela VB Correspondence Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62:2708-14. Re K. Sawada et al., Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62:6015-20. 2004 Cancer Res. pmid:15087415
Boucher Y et al. Origins and evolution of isoprenoid lipid biosynthesis in archaea. 2004 Mol. Microbiol. pmid:15066037
Blanco-Colio LM et al. Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin. 2004 J. Am. Coll. Cardiol. pmid:15063428
Reichart B et al. Expression and localization of nuclear proteins in autosomal-dominant Emery-Dreifuss muscular dystrophy with LMNA R377H mutation. 2004 BMC Cell Biol. pmid:15053843
Begley M et al. The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes. 2004 FEBS Lett. pmid:15013758
Thompson K and Rogers MJ Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro. 2004 J. Bone Miner. Res. pmid:14969398
Hedl M and Rodwell VW Enterococcus faecalis mevalonate kinase. 2004 Protein Sci. pmid:14767074
Turunen M et al. Metabolism and function of coenzyme Q. 2004 Biochim. Biophys. Acta pmid:14757233
Kasahara H et al. Distinct isoprenoid origins of cis- and trans-zeatin biosyntheses in Arabidopsis. 2004 J. Biol. Chem. pmid:14726522
Raupp P et al. Novel genotype of mevalonic aciduria with fatalities in premature siblings. 2004 Arch. Dis. Child. Fetal Neonatal Ed. pmid:14711867
Rodríguez-Concepción M et al. Distinct light-mediated pathways regulate the biosynthesis and exchange of isoprenoid precursors during Arabidopsis seedling development. 2004 Plant Cell pmid:14660801
Le Jossic-Corcos C et al. Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes. 2004 Biochim. Biophys. Acta pmid:15238219
Fortin DL et al. Lipid rafts mediate the synaptic localization of alpha-synuclein. 2004 J. Neurosci. pmid:15282274
Thorpe JL et al. Germ cell migration in zebrafish is dependent on HMGCoA reductase activity and prenylation. 2004 Dev. Cell pmid:14960282
Hong SB et al. Role of the non-mevalonate pathway in indole alkaloid production by Catharanthus roseus hairy roots. 2003 May-Jun Biotechnol. Prog. pmid:12790690
Awad AB et al. Effect of phytosterols on cholesterol metabolism and MAP kinase in MDA-MB-231 human breast cancer cells. 2003 J. Nutr. Biochem. pmid:12667603
Zacco A et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. 2003 J. Neurosci. pmid:14657168
Kaneta S et al. All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells. 2003 Atherosclerosis pmid:14612203
Huang KC et al. Statins induce suppressor of cytokine signaling-3 in macrophages. 2003 FEBS Lett. pmid:14644448
Dong J et al. Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in hypertensives. 2003 Hypertens. Res. pmid:14620928